Kymera Therapeutics KYMR
NASDAQ KYMR
$107.39 -2.73 (-2.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kymera Therapeutics (KYMR) Other Non Operating Income (2019 - 2026)

Updated

Kymera Therapeutics (KYMR) recorded Other Non Operating Income of $14.48 million in Q2 2026, up 79.8% from $8.05 million a year earlier but down 3.4% from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) Other Non Operating Income (2019 - 2026) Analysis & Trends

On a TTM basis, Kymera Therapeutics' Other Non Operating Income came in at $50.91 million as of Jun 30, 2026, up 38.6% year-over-year; for FY2025, it was $38.42 million, up 1.0% from FY2024.

  • Annual Other Non Operating Income has increased for three straight years, with a five-year compound annual growth rate of 115.5% (FY2020 to FY2025).
  • Across earlier years, Other Non Operating Income came in at $38.03 million in FY2024 (+102.7%), $18.76 million in FY2023 (+183.3%), $6.62 million in FY2022 and $488,000 in FY2021 (-40.9%).
  • Quarterly Other Non Operating Income has ranged from $125,000 in Q3 2021 to $14.98 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Other Non Operating Income has increased for four consecutive quarters, with growth averaging 44.9% over the last eight quarters.
  • Peak year-over-year performance for Other Non Operating Income in the last five years was growth of 679.8% in Q2 2023, against a decline of 9.8% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $14.98 million (Q1 2026), $11.01 million (Q4 2025) and $10.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Kymera Therapeutics 8.89 Bn 6.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.48 Mn
Mar 31, 2026 14.98 Mn
Dec 31, 2025 11.01 Mn
Sep 30, 2025 10.44 Mn
Jun 30, 2025 8.05 Mn
Mar 31, 2025 8.92 Mn
Dec 31, 2024 10.06 Mn
Sep 30, 2024 9.70 Mn
Jun 30, 2024 8.92 Mn
Mar 31, 2024 9.34 Mn
Dec 31, 2023 5.00 Mn
Sep 30, 2023 4.68 Mn
Jun 30, 2023 4.63 Mn
Mar 31, 2023 4.45 Mn
Dec 31, 2022 3.82 Mn
Sep 30, 2022 1.92 Mn
Jun 30, 2022 594,000.00
Mar 31, 2022 290,000.00
Dec 31, 2021 145,000.00
Sep 30, 2021 125,000.00
API Access

Kymera Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=KYMR&period=max&api_key=YOUR_API_KEY